MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 110 filers reported holding MYOVANT SCIENCES LTD in Q2 2021. The put-call ratio across all filers is 4.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $101,000 | +44.3% | 5,643 | 0.0% | 0.00% | – |
| Q2 2022 | $70,000 | +18.6% | 5,643 | +48.4% | 0.00% | – |
| Q4 2021 | $59,000 | +391.7% | 3,803 | +563.7% | 0.00% | – |
| Q3 2021 | $12,000 | -78.6% | 573 | -76.7% | 0.00% | – |
| Q2 2021 | $56,000 | +1300.0% | 2,461 | +599.1% | 0.00% | – |
| Q3 2020 | $4,000 | -99.0% | 352 | -98.6% | 0.00% | -100.0% |
| Q4 2018 | $417,000 | -38.2% | 25,443 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $675,000 | +103.9% | 25,443 | +75.6% | 0.00% | 0.0% |
| Q2 2018 | $331,000 | – | 14,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
| Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
| PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
| Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
| Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
| Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
| Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
| Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
| Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |